Abdel Ghafar MT. 2019. Association of aldosterone synthase CYP11B2 (-344C/T) gene polymorphism with essential hypertension and left ventricular hypertrophy in the Egyptian population. Clin Exp Hypertens. 41(8):779–786. doi:10.1080/10641963.2018.1557679.
Abdel Ghafar MT. 2020. An overview of the classical and tissue-derived renin-angiotensin-aldosterone system and its genetic polymorphisms in essential hypertension. Steroids. 163:108701. doi:https://doi.org/10.1016/j.steroids.2020.108701.
Al-Ali AK, Al-Muhana FA, Larbi EB, Abdulmohsen MF, Al-Sultan AI, Al-Maden MS, Al-Ateeq SA. 2005. Frequency of methylenetetrahydrofolate reductase C677T polymorphism in patients with cardiovascular disease in Eastern Saudi Arabia. Saudi Med J. 26(12):1886–1888.
AlRasheed MM, Hefnawy MM, Elsherif NN, Alhawassi TM, Abanmy NO, AlRasheed NM, Alqahtani FY, Aleanizy FS, Muiya P, Al-Boudari OM, et al. 2018. The role of CDKN2B in cardiovascular risk in ethnic Saudi Arabs: A validation study. Gene. 673:206–210. doi:10.1016/j.gene.2018.06.024.
Antonio-Véjar V., Del Moral-Hernández O, Alarcón-Romero LC, Flores-Alfaro E, Leyva-Vázquez MA, Hernández-Sotelo D, Illades-Aguiar B. 2014. Ethnic variation of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate-reductase (MTHFR) gene in southwestern mexico. Genetics and Molecular Research. 13(3):7950–7957. doi:10.4238/2014.September.29.8.
Antonio-Véjar V, Del Moral-Hernández O, Alarcón-Romero LC, Flores-Alfaro E, Leyva-Vázquez MA, Hernández-Sotelo D, Illades-Aguiar B. 2014. Ethnic variation of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate-reductase (MTHFR) gene in southwestern Mexico. Genet Mol Res. 13(3):7950–7957. doi:10.4238/2014.September.29.8.
Barua L, Faruque M, Banik PC, Ali L. 2019. Atherogenic index of plasma and its association with cardiovascular disease risk factors among postmenopausal rural women of Bangladesh. Indian Heart J. 71(2):155–160. doi:10.1016/j.ihj.2019.04.012.
Basol N, Karakus N, Savas AY, Kaya I, Karakus K, Yigit S. 2016. The importance of MTHFR C677T/A1298C combined polymorphisms in pulmonary embolism in Turkish population. Medicina (Kaunas). 52(1):35–40. doi:10.1016/j.medici.2016.01.003.
Bhardwaj S, Bhattacharjee J, Bhatnagar MK, Tyagi S, Delhi N. 2013. Atherogenic index of plasma, castelli risk index and atherogenic coefficient - new parameters in assessing cardiovascular risk. Int J Pharm Biol Sci. 3(3):359–364.
Calderón-Garcidueñas AL, Cerda-Flores RM, Castruita-Ávila AL, González-Guerrero JF, Barrera-Saldaña HA. 2017. [C677T-SNP of methylenetetrahydrofolate reductase gene and breast cancer in Mexican women]. Rev Med Inst Mex Seguro Soc. 55(6):720–724.
Caliskan Z, Demircioglu K, Sayar S, Kahraman R, Caklili O, Ozcan FB, Kostek O, Baycan OF, Doganay HL, Caliskan M. 2019. Lipid profile, atherogenic indices, and their relationship with epicardial fat thickness and carotid intima-media thickness in celiac disease. North Clin Istanb. 6(3):242–247. doi:10.14744/nci.2019.54936.
Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. 1991. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 324(17):1149–1155. doi:10.1056/NEJM199104253241701.
Crider KS, Yang TP, Berry RJ, Bailey LB. 2012. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate’s role. Adv Nutr. 3(1):21–38. doi:10.3945/an.111.000992.
Cure E, Icli A, Uslu AU, Sakiz D, Cure MC, Baykara RA, Yavuz F, Arslan S, Kucuk A. 2018. Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis. Clin Rheumatol. 37(5):1273–1280. doi:10.1007/s10067-018-4027-0.
Dagneaux L, Owen AR, Bettencourt JW, Barlow JD, Amadio PC, Kocher JP, Morrey ME, Sanchez-Sotelo J, Berry DJ, van Wijnen AJ, et al. 2020 Jun. Human Fibrosis: Is There Evidence for a Genetic Predisposition in Musculoskeletal Tissues? J Arthroplasty. doi:10.1016/j.arth.2020.05.070.
D’Agostino RBS, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. 2008. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 117(6):743–753. doi:10.1161/CIRCULATIONAHA.107.699579.
Dobiášová M. 2004. Atherogenic Index of Plasma [Log(Triglycerides/HDL-Cholesterol)]: Theoretical and Practical Implications. Clin Chem. 50(7):1113 LP – 1115.
Dobiasova M. 2006. [AIP--atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice]. Vnitr Lek. 52(1):64–71.
Dobiasova M, Frohlich J. 2000. [The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy]. Vnitr Lek. 46(3):152–156.
Dobiasova M, Frohlich J. 2001. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 34(7):583–588.
Dobiášová M, Frohlich J. 2001. The plasma parameter log (TG/HDL-C) as an atherogenic index: Correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FER HDL). Clin Biochem. 34(7):583–588. doi:10.1016/S0009-9120(01)00263-6.
Edwards MK, Blaha MJ, Loprinzi PD. 2017. Atherogenic Index of Plasma and Triglyceride/High-Density Lipoprotein Cholesterol Ratio Predict Mortality Risk Better Than Individual Cholesterol Risk Factors, Among an Older Adult Population. Mayo Clin Proc. 92(4):680–681. doi:10.1016/j.mayocp.2016.12.018.
Essiarab F, Taki H, Lebrazi H, Sabri M, Saïle R. 2014. Usefulness of lipid ratios and atherogenic index of plasma in obese Moroccan women with or without metabolic syndrome. Ethn Dis. 24(2):207–212.
Fernandez-Macias JC, Ochoa-Martinez AC, Varela-Silva JA, Perez-Maldonado IN. 2019. Atherogenic Index of Plasma: Novel Predictive Biomarker for Cardiovascular Illnesses. Arch Med Res. 50(5):285–294. doi:10.1016/j.arcmed.2019.08.009.
Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge. Clin Chem. 18(6):499 LP – 502.
Frohlich J, Dobiasova M. 2003a. Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography. Clin Chem. 49(11):1873–1880.
Frohlich J, Dobiasova M. 2003b. Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography. Clin Chem. 49(11):1873–1880.
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 10(1):111–113. doi:10.1038/ng0595-111.
García-González I, López-Díaz RI, Canché-Pech JR, Solís-Cárdenas A de J, Flores-Ocampo JA, Mendoza-Alcocer R, Herrera-Sánchez LF, Jiménez-Rico MA, Ceballos-López AA, López-Novelo ME. 2018a. Epistasis analysis of metabolic genes polymorphisms associated with ischemic heart disease in Yucatan. Clin Investig Arterioscler. 30(3):102–111. doi:10.1016/j.arteri.2017.11.002.
García-González I, López-Díaz RI, Canché-Pech JR, Solís-Cárdenas A de J, Flores-Ocampo JA, Mendoza-Alcocer R, Herrera-Sánchez LF, Jiménez-Rico MA, Ceballos-López AA, López-Novelo ME. 2018b. Epistasis analysis of metabolic genes polymorphisms associated with ischemic heart disease in Yucatan. Clin Investig Arterioscler. 30(3):102–111. doi:10.1016/j.arteri.2017.11.002.
Gerber PA, Nikolic D, Rizzo M. 2017. Small, dense LDL: an update. Curr Opin Cardiol. 32(4):454–459. doi:10.1097/HCO.0000000000000410.
Ghafar MTA, Shalaby KH, Okda HI, Rizk FH. 2020. Association of ABCA1 (C69T) gene polymorphism with dyslipidemia and type 2 diabetes among the Egyptian population. Meta Gene. 25:100714. doi:https://doi.org/10.1016/j.mgene.2020.100714.
González Block MA, Figueroa-Lara A, Ávila Burgos L, Balandrán-Duarte DA, Aracena-Genao B, Cahuana-Hurtado L, Guerrero-López CM. 2017. Retos a la Encuesta Nacional de Salud y Nutrición 2017. Salud Publica Mex. 59(2):126–127. doi:10.21149/8214.
Graydon JS, Claudio K, Baker S, Kocherla M, Ferreira M, Roche-Lima A, Rodríguez-Maldonado J, Duconge J, Ruaño G. 2019. Ethnogeographic prevalence and implications of the 677C>T and 1298A>C MTHFR polymorphisms in US primary care populations. Biomark Med. 13(8):649–661. doi:10.2217/bmm-2018-0392.
El Hajj Chehadeh SW, Jelinek HF, Al Mahmeed WA, Tay GK, Odama UO, Elghazali GEB, Al Safar HS. 2016. Relationship between MTHFR C677T and A1298C gene polymorphisms and complications of type 2 diabetes mellitus in an Emirati population. Meta Gene. 9:70–75. doi:10.1016/j.mgene.2016.04.002.
Haybar H, Jalali MT, Zayeri ZD. 2018. What Genetics Tells us about Cardiovascular Disease in Diabetic Patients? Cardiovasc Hematol Disord Drug Targets. 18(2):147–152. doi:10.2174/1871529X18666180212114305.
Hernández-Guerrero C, Romo-Palafox I, Díaz-Gutiérrez MC, Iturbe-García M, Texcahua-Salazar A, Pérez-Lizaur AB. 2013a. Prevalencia del polimorfismo C677T de la metilentetrahidrofolato reductasa, consumo de las vitaminas B6, B9, B12 y determinación de hidroperóxidos lipídicos en población mexicana obesa y con peso normal. Nutr Hosp. 28(6):2142–2150. doi:10.3305/nh.2013.28.6.6902.
Hernández-Guerrero C, Romo-Palafox I, Díaz-Gutiérrez MC, Iturbe-García M, Texcahua-Salazar A, Pérez-Lizaur AB. 2013b. Prevalence of metilentetrahidrofolate reductase C677T polymorphism, consumption of vitamins B6, B9, B12 and determination of lipidic hydroperoxides in obese and normal weight Mexican population. Nutr Hosp. 28(6):2142–2150.
Heux S, Morin F, Lea RA, Ovcaric M, Tajouri L, Griffiths LR. 2004. The methylentetrahydrofolate reductase gene variant (C677T) as a risk factor for essential hypertension in Caucasians. Hypertens Res. 27(9):663–667. doi:10.1291/hypres.27.663.
Hoogeveen RC, Gaubatz JW, Sun W, Dodge RC, Crosby JR, Jiang J, Couper D, Virani SS, Kathiresan S, Boerwinkle E, et al. 2014. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol. 34(5):1069–1077. doi:10.1161/ATVBAHA.114.303284.
Hou J, Zeng X, Xie Y, Wu H, Zhao P. 2018. Genetic polymorphisms of methylenetetrahydrofolate reductase C677T and risk of ischemic stroke in a southern Chinese Hakka population. Medicine. 97(51):e13645. doi:10.1097/MD.0000000000013645.
Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. 1996. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 93(1):7–9. doi:10.1161/01.cir.93.1.7.
Kamoru AA, Japhet OM, Adetunji AD, Musa MA, Hammed OO, Akinlawon AA, Abdufatah OA, Taofik AA, Kabiru AA, Roji SM. 2017. Castelli Risk Index, Atherogenic Index of Plasma, and Atherogenic Coefficient: Emerging Risk Predictors of Cardiovascular Disease in HIV-Treated Patients. Saudi Journal of Medical and Pharmaceutical Sciences. 4929:1101–1110. doi:10.21276/sjmps.2017.3.10.15.
Kennedy DA, Stern SJ, Matok I, Moretti ME, Sarkar M, Adams-Webber T, Koren G. 2012. Folate Intake, MTHFR Polymorphisms, and the Risk of Colorectal Cancer: A Systematic Review and Meta-Analysis. J Cancer Epidemiol. 2012:952508. doi:10.1155/2012/952508.
Kerkeni M, Addad F, Chauffert M, Myara A, Gerhardt M, Chevenne D, Trivin F, Farhat M Ben, Miled A, Maaroufi K. 2006. Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease. Ann Clin Biochem. 43(Pt 3):200–206. doi:10.1258/000456306776865232.
Lakkakula BVKS. 2019. Association between MTHFR 677C>T polymorphism and vascular complications in sickle cell disease: A meta-analysis. Transfus Clin Biol. 26(4):284–288. doi:10.1016/j.tracli.2019.01.003.
Li M, Fu B, Dong W. 2018. Correlations between plasma homocysteine and MTHFR gene polymorphism and white matter lesions. Folia Neuropathol. 56(4):301–307. doi:10.5114/fn.2018.80863.
Liew S-C, Gupta E Das. 2015. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases. Eur J Med Genet. 58(1):1–10. doi:10.1016/j.ejmg.2014.10.004.
Liu J, Wang G, Peng Z. 2020. Association between the MMP-1-1607 1G/2G Polymorphism and Osteoarthritis Risk: A Systematic Review and Meta-Analysis. Biomed Res Int. 2020:5190587. doi:10.1155/2020/5190587.
Liu P-F, Ding B, Zhang J-Y, Mei X-F, Li F, Wu P, Mei C-H, Zhou Y-F, Chen T. 2020. Association Between MTHFR C677T Polymorphism and Congenital Heart Disease. Int Heart J. 61(3):553–561. doi:10.1536/ihj.19-389.
Marosi K, Agota A, Vegh V, Joo JG, Langmar Z, Kriszbacher I, Nagy ZB. 2012. [The role of homocysteine and methylenetetrahydrofolate reductase, methionine synthase, methionine synthase reductase polymorphisms in the development of cardiovascular diseases and hypertension]. Orv Hetil. 153(12):445–453. doi:10.1556/OH.2012.29326.
Mazzuca F, Borro M, Botticelli A, Aimati L, Gentile G, Capalbo C, Maddalena C, Mazzotti E, Simmaco M, Marchetti P. 2015. Effect of MTHFR Polymorphisms on Gastrointestinal Cancer Risk in Italy. World J Oncol. 6(4):394–397. doi:10.14740/wjon930w.
Mikhaylenko DS, Nemtsova M V, Bure I V, Kuznetsova EB, Alekseeva EA, Tarasov V V, Lukashev AN, Beloukhova MI, Deviatkin AA, Zamyatnin AAJ. 2020. Genetic Polymorphisms Associated with Rheumatoid Arthritis Development and Antirheumatic Therapy Response. Int J Mol Sci. 21(14). doi:10.3390/ijms21144911.
Ochoa-Martínez ÁC, Ruíz-Vera T, Almendarez-Reyna CI, Orta-García ST, Pérez-Maldonado IN. 2017. Influence on serum asymmetric dimethylarginine (ADMA) concentrations of human paraoxonase 1 polymorphism (Q192R) and exposure to polycyclic aromatic hydrocarbons (PAHs) in Mexican women, a gene-environment interaction. Chemosphere. 186. doi:10.1016/j.chemosphere.2017.08.055.
Ochoa-Martínez ÁC, Ruiz-Vera T, Almendarez-Reyna CI, Zarazúa S, Carrizales-Yáñez L, Pérez-Maldonado IN. 2019. Impact of arsenic exposure on clinical biomarkers indicative of cardiovascular disease risk in Mexican women. Ecotoxicol Environ Saf. 169(550):678–686. doi:10.1016/j.ecoenv.2018.11.088.
Ochoa-Martinez AC, Ruiz-Vera T, Orta-Garcia ST, Dominguez-Cortinas G, Jimenez-Avalos JA, Perez-Maldonado IN. 2017. Association between Q192R paraoxonase 1 polymorphism and serumadipocyte-fatty acid binding protein (FABP4) levels in Mexican women. Ann Hum Biol. 44(4):389–391. doi:10.1080/03014460.2016.1245785.
Ochoa-Martinez AC, Ruiz-Vera T, Pruneda-Alvarez LG, Gonzalez-Palomo AK, Almendarez-Reyna CI, Perez-Vazquez FJ, Perez-Maldonado IN. 2017. Serum adipocyte-fatty acid binding protein (FABP4) levels in women from Mexico exposed to polycyclic aromatic hydrocarbons (PAHs). Environ Sci Pollut Res Int. 24(2):1862–1870. doi:10.1007/s11356-016-7971-8.
Olivi L, Gu YM, Salvi E, Liu YP, Thijs L, Velayutham D, Jin Y, Jacobs L, D’Avila F, Petit T, et al. 2015. The -665 C>T polymorphism in the eNOS gene predicts cardiovascular mortality and morbidity in white Europeans. J Hum Hypertens. 29(3):167–172. doi:10.1038/jhh.2014.66.
Onat A, Can G, Kaya H, Hergenc G. 2010. “Atherogenic index of plasma” (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipidol. 4(2):89–98. doi:10.1016/j.jacl.2010.02.005.
Peng X, Zhou Y, Wu X, Wang X, Bai H, Li Y, Wang Z, Chen X, Wang Y. 2020. Association of methylenetetrahydrofolate reductase (MTHFR) variant C677T and risk of carotid atherosclerosis: a cross-sectional analysis of 730 Chinese Han adults in Chongqing. BMC Cardiovasc Disord. 20(1):222. doi:10.1186/s12872-020-01505-1.
Pruneda-Alvarez LG, Ruiz-Vera T, Ochoa-Martinez AC, Perez-Vazquez FJ, Gonzalez Palomo AK, Ilizaliturri-Hernandez CA, Perez-Maldonado IN. 2016 Aug. Plasma asymmetric dimethylarginine (ADMA) levels in Mexican women exposed to polycyclic aromatic hydrocarbons (PAHs): A preliminary study. Sci Total Environ. doi:10.1016/j.scitotenv.2016.08.037.
Qin Z, Zhou K, Li Y, Cheng W, Wang Z, Wang J, Gao F, Yang L, Xu Y, Wu Y, et al. 2020. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China. Cardiovasc Diabetol. 19(1):23. doi:10.1186/s12933-020-0989-8.
Ramos-Silva A, Figuera LE, Soto-Quintana OM, Puebla-Pérez AM, Ramírez-Patiño R, Gutiérrez-Hurtado I, Carrillo-Moreno DI, Zúñiga-González GM, Dávalos-Rodríguez IP, Gallegos-Arreola MP. 2015. Association of the C677T polymorphism in the methylenetetrahydrofolate reductase gene with breast cancer in a Mexican population. Genet Mol Res. 14(2):4015–4026. doi:10.4238/2015.April.27.16.
Ruiz-Vera T, Ochoa-Martínez ÁC, Pruneda-Álvarez LG, Domínguez-Cortinas G, Pérez-Maldonado IN. 2019. Expression levels of circulating microRNAs-126, -155, and -145 in Mexican women exposed to polycyclic aromatic hydrocarbons through biomass fuel use. Environ Mol Mutagen. 60(6):546–558. doi:10.1002/em.22273.
Ruiz-Vera T, Ochoa-Martinez AC, Pruneda-Alvarez LG, Zarazua S, Perez-Maldonado IN. 2019. Exposure to biomass smoke is associated with an increased expression of circulating miRNA-126 and miRNA-155 in Mexican women: a pilot study. Drug Chem Toxicol. 42(3):335–342. doi:10.1080/01480545.2018.1526181.
Ruiz-Vera T, Ochoa-Martinez AC, Zarazua S, Carrizales-Yanez L, Perez-Maldonado IN. 2019. Circulating miRNA-126, -145 and -155 levels in Mexican women exposed to inorganic arsenic via drinking water. Environ Toxicol Pharmacol. 67:79–86. doi:10.1016/j.etap.2019.02.004.
Ruiz-Vera T, Pruneda-Álvarez LG, Ochoa-Martínez ÁC, Ramírez-GarcíaLuna JL, Pierdant-Pérez M, Gordillo-Moscoso AA, Pérez-Vázquez FJ, Pérez-Maldonado IN. 2015. Assessment of vascular function in Mexican women exposed to polycyclic aromatic hydrocarbons from wood smoke. Environ Toxicol Pharmacol. 40(2):423–429. doi:10.1016/j.etap.2015.07.014.
Santos HO, Earnest CP, Tinsley GM, Izidoro LFM, Macedo RCO. 2020 Apr. Small dense low-density lipoprotein-cholesterol (sdLDL-C): Analysis, effects on cardiovascular endpoints and dietary strategies. Prog Cardiovasc Dis. doi:10.1016/j.pcad.2020.04.009.
Shunmoogam N, Naidoo P, Chilton R. 2018. Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance. Vasc Health Risk Manag. 14:137–143. doi:10.2147/VHRM.S165173.
Silva NNT, Sabino A de P, Tafuri A, Lima AA. 2019. Lack of association between methylenetetrahydrofolate reductase C677T polymorphism, HPV infection and cervical intraepithelial neoplasia in Brazilian women. BMC Med Genet. 20(1):100. doi:10.1186/s12881-019-0831-x.
SoRelle R. 2002. ATP III calls for more intensive low-density lipoprotein lowering in target groups. Circulation. 106(25):e9068-8. doi:10.1161/01.cir.0000052861.81153.18.
Surdacki A, Martens-Lobenhoffer J, Wloch A, Marewicz E, Rakowski T, Wieczorek-Surdacka E, Dubiel JS, Pryjma J, Bode-Böger SM. 2007. Elevated plasma asymmetric dimethyl-L-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis. Arthritis Rheum. 56(3):809–819. doi:10.1002/art.22424.
Tecer D, Sunar I, Ozdemirel AE, Tural R, Kucuksahin O, Sepici Dincel A, Ataman S. 2019. Usefullnes of atherogenic indices and Ca-LDL level to predict subclinical atherosclerosis in patients with psoriatic arthritis? Adv Rheumatol. 59(1):49. doi:10.1186/s42358-019-0096-2.
Thirumaran RK, Gast A, Flohr T, Burwinkel B, Bartram C, Hemminki K, Kumar R. 2005. MTHFR genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Blood. 106(7):2590–2592. doi:10.1182/blood-2005-04-1719.
Toft-Petersen AP, Tilsted HH, Aarøe J, Rasmussen K, Christensen T, Griffin BA, Aardestrup I V, Andreasen A, Schmidt EB. 2011. Small dense LDL particles--a predictor of coronary artery disease evaluated by invasive and CT-based techniques: a case-control study. Lipids Health Dis. 10:21. doi:10.1186/1476-511X-10-21.
Tongdee P, Nimkuntod P. 2016. Novel Mathematic Indexes to Identify Subclinical Atherosclerosis in Different Obesity Phenotypes of Perimenopausal/Menopausal Women. J Med Assoc Thai. 99 Suppl 7:S62-8.
Tripathi R, Tewari S, Singh PK, Agarwal S. 2010. Association of homocysteine and methylene tetrahydrofolate reductase (MTHFR C677T) gene polymorphism with coronary artery disease (CAD) in the population of North India. Genet Mol Biol. 33(2):224–228. doi:10.1590/S1415-47572010005000026.
Tsang BL, Devine OJ, Cordero AM, Marchetta CM, Mulinare J, Mersereau P, Guo J, Qi YP, Berry RJ, Rosenthal J, et al. 2015. Assessing the association between the methylenetetrahydrofolate reductase (MTHFR) 677C>T polymorphism and blood folate concentrations: a systematic review and meta-analysis of trials and observational studies. Am J Clin Nutr. 101(6):1286–1294. doi:10.3945/ajcn.114.099994.
Urbina EM, Williams R V, Alpert BS, Collins RT, Daniels SR, Hayman L, Jacobson M, Mahoney L, Mietus-Snyder M, Rocchini A, et al. 2009. Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension. 54(5):919–950. doi:10.1161/HYPERTENSIONAHA.109.192639.
Vasan RS. 2006. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation. 113(19):2335–2362. doi:10.1161/CIRCULATIONAHA.104.482570.
Vazquez-Alaniz F, Lumbreras-Márquez MI, Sandoval-Carrillo AA, Aguilar-Durán M, Méndez-Hernández EM, Barraza-Salas M, Castellanos-Juárez FX, Salas-Pacheco JM. 2014. Association of COMT G675A and MTHFR C677T polymorphisms with hypertensive disorders of pregnancy in Mexican mestizo population. Pregnancy Hypertens. 4(1):59–64. doi:10.1016/j.preghy.2013.11.002.
Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. 1998. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab. 64(3):169–172. doi:10.1006/mgme.1998.2714.
Whayne TFJ. 2015. Methylenetetrahydrofolate reductase C677T polymorphism, venous thrombosis, cardiovascular risk, and other effects. Angiology. 66(5):401–404. doi:10.1177/0003319714548871.
WHO. 2014. Global status report on noncommunicable diseases 2014. World Health.:176. doi:ISBN 9789241564854.
WHO. World Heart Federation. World Stroke Organization. 2011. Global Atlas on Cardiovascular disease prevention and control. Published by the World Health Organization in collaboration with the World Heart Federation the World Heart Federation and the World Stroke Organization.:155. doi:NLM classification: WG 120.
Yang Q, Bailey L, Clarke R, Flanders WD, Liu T, Yesupriya A, Khoury MJ, Friedman JM. 2012. Prospective study of methylenetetrahydrofolate reductase (MTHFR) variant C677T and risk of all-cause and cardiovascular disease mortality among 6000 US adults. Am J Clin Nutr. 95(5):1245–1253. doi:10.3945/ajcn.111.022384.
Yu D, Zhuang Z, Wen Z, Zang X, Mo X. 2017. MTHFR A1298C polymorphisms reduce the risk of congenital heart defects: a meta-analysis from 16 case-control studies. Ital J Pediatr. 43(1):108. doi:10.1186/s13052-017-0425-1.